Suanfarma, at the Core of a Better Life.
01 1Suanfarma
02 1Zhejiang Hengkang Pharmaceutical
03 1Tagoor Laboratories
04 1CTX Lifesciences
05 1Cangzhou Enke Pharma-tech Co., Ltd
06 1Cangzhou Senary Chemical Science-tech Co., Ltd
07 2Curequest Lifescience
08 1Kimia Biosciences
09 1LifeFirst Pharma
10 1Nanjing Lift Pharmaceutical Technology Co., Ltd
11 1Ocimum Labs
12 1Om Pharmaceutical Industries
13 1Prajna Generics
14 1Sandoo Pharmaceuticals and Chemcials Co.,Ltd
15 1Shodhana Laboratories
16 1Sigmak Lifesciences
17 1Smruthi Organics
18 1Synaptics Labs
19 1Vidgas Science & Technologies
Suanfarma, at the Core of a Better Life.
(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health advancement by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry i...
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to gl...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth...
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Anagliptin
About the Company : Cangzhou Enke Pharma Tech Co.,ltd. is located in Cangzhou City, Hebei province ,where is a famous petroleum chemical industry city in China. Enke Pharma a high-tech enterprise ,and we a...
(2S)-1-chloroacetyl-2-pyrrolidine carbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Anagliptin, Vildagliptin
About the Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cang...
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : CTX is one of the youngest and fastest-growing Indian API and Intermediate manufacturing companies doing business in over 70 countries. In these five years, all my thoughts and actions ...
(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : Curequest lifescience LLP is in the business of manufacturing and exports of Active Pharmaceutical Ingredients (APIs) and API Intermediates. We are a team of young techno-commercial pro...
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile.
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : Curequest lifescience LLP is in the business of manufacturing and exports of Active Pharmaceutical Ingredients (APIs) and API Intermediates. We are a team of young techno-commercial pro...
(2S)-1-(Chloroacetyl)-2- pyrrolidine-carbonitrile ...
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia ai...
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
CAS Number : 207557-35-5
End Use API :
End Use API : Vildagliptin
About the Company : We believe in attaining the highest levels of customer satisfaction and social welfare with the philosophy of keeping first things first. Our systematic interventions keeping abreast of...
